VRS_023 - A case report of drug-induced liver injury (DILI) in a cervical cancer patient treated with toripalimab combined with chemotherapy

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: VRS_023
• By: WANG, Yanting
• Co-author(s): Dr Yanting Wang
  Ms. Peipei Yan
  Dr Min Cheng
  
• Abstract:

  Introduction: Toripalimab, a PD-1 inhibitor, has been approved for the treatment of melanoma, urothelial cancer, nasopharyngeal cancer, esophageal squamous cell cancer, non-small cell lung cancer, renal cancer, small cell lung cancer, and triple negative breast cancer. It has not been approved to treat cervical cancer, and the case of DILI caused..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login